Table 1.
Demographic and clinical variables according to etiology of salivary gland disease with statistical non-parametrical evaluation (Kruskal–Wallis or Chi-Square test) n = 160.
| Variable | Sialolithiasis (n = 51) | Post-radioiodine therapy (n = 42) | Autoimmune disease (n = 34) | Non-specific chronic sialadenitis (n = 33) | p-valor |
|---|---|---|---|---|---|
| Age: years (SD) | 51.6 (16.8) | 44.6 (14.6) | 41.6 (16.5) | 57.7 (17.1) | <0.001 |
| Follow-up: months (SD) | 14.0 (20.7) | 27.6 (29.4) | 9.06 (13.9) | 16.4 (22.5) | 0.003 |
| Recurrence within 6 months (%): | 0.017 | ||||
| No | 43 (84.3%) | 42 (100%) | 29 (85.3%) | 31 (93.9%) | |
| Yes | 8 (15.7%) | 0 (0.00%) | 5 (14.7%) | 2 (6.06%) | |
| Gender (%): | <0.001 | ||||
| Female (%) | 27 (52.9%) | 39 (92.9%) | 30 (88.2%) | 20 (60.6%) | |
| Male (%) | 24 (47.1%) | 3 (7.14%) | 4 (11.8%) | 13 (39.4%) | |
| Affected gland (%): | <0.001 | ||||
| Parotid | 19 (37.3%) | 37 (88.1%) | 32 (94.1%) | 14 (42.4%) | |
| Submandibular | 32 (62.7%) | 5 (11.9%) | 2 (5.88%) | 19 (57.6%) | |
| Side (%): | 0.575 | ||||
| Right | 29 (56.9%) | 19 (45.2%) | 15 (44.1%) | 15 (45.5%) | |
| Left | 22 (43.1%) | 23 (54.8%) | 19 (55.9%) | 18 (54.5%) | |
| Complications: | 0.014 | ||||
| No | 41 (80.4%) | 41 (97.6%) | 33 (97.1%) | 28 (84.8%) | |
| Yes | 10 (19.6%) | 1 (2.38%) | 1 (2.94%) | 5 (15.2%) |
Results are expressed as mean (standard deviation) or n (%).
Source: Original research results.